C.E.Management Integrated Laboratory Co.LtdJP:6171
Market cap
¥5.9B
P/E ratio
13.8x
| 2013/12 | 2014/12 | 2015/12 | 2016/12 | 2017/12 | 2018/12 | 2019/12 | 2020/12 | 2021/12 | 2022/12 | 2023/12 | 2024/12 | |
| Cash and cash equivalents | - | 362 | 1,258 | 1,078 | 990 | 1,038 | 1,169 | 1,362 | 1,811 | 1,747 | 2,138 | 2,271 |
| Accounts receivable, net | - | 681 | 748 | 782 | - | 881 | 953 | 1,030 | 1,350 | - | - | - |
| Total current assets | - | 1,322 | 2,226 | 2,187 | 2,156 | 2,391 | 2,562 | 2,948 | 3,572 | 3,670 | 3,816 | 4,027 |
| Property, plant and equipment, net | - | 835 | 849 | 968 | 1,421 | 1,917 | 2,039 | 2,106 | 2,303 | 2,193 | 2,103 | 2,241 |
| Marketable securities, non-current | - | 21 | 13 | 130 | 281 | 665 | 684 | 502 | 307 | 343 | 387 | 354 |
| Total non-current assets | - | 974 | 970 | 1,205 | 1,822 | 2,821 | 3,008 | 3,140 | 3,343 | 3,328 | 3,046 | 3,001 |
| Total assets | - | 2,295 | 3,196 | 3,392 | 3,978 | 5,212 | 5,570 | 6,088 | 6,915 | 6,998 | 6,861 | 7,029 |
| Short-term debt | - | 90 | - | - | - | - | - | - | - | - | - | - |
| Long-term debt, current | - | 30 | - | - | - | - | - | 57 | 178 | 217 | 217 | 171 |
| Total current liabilities | - | 917 | 641 | 663 | 680 | 868 | 962 | 1,093 | 1,397 | 1,244 | 1,253 | 1,282 |
| Long-term debt, non-current | - | 88 | - | - | - | - | - | 158 | 734 | 708 | 495 | 324 |
| Total non-current liabilities | - | 328 | 262 | 283 | 319 | 335 | 397 | 595 | 1,160 | 1,180 | 977 | 873 |
| Total liabilities | - | 1,244 | 903 | 946 | 999 | 1,203 | 1,359 | 1,688 | 2,557 | 2,424 | 2,230 | 2,156 |
| Common stock and paid-in capital | - | 118 | 1,092 | 1,098 | 1,479 | 2,313 | 2,313 | 2,360 | 2,360 | 2,360 | 2,360 | 2,362 |
| Retained earnings | - | 953 | 1,219 | 1,369 | 1,509 | 1,729 | 1,923 | 2,086 | 2,003 | 2,204 | 2,231 | 2,423 |
| Stockholders' equity | 911 | 1,051 | 2,292 | 2,446 | 2,979 | 4,009 | 4,211 | 4,400 | 4,358 | 4,573 | 4,631 | 4,873 |